Jane Street’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Jane Street’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-173	Closed	-$3K	–	10631
2022 Q2	$3K	Buy	+173	New	+$4.33K	﹤0.01%	9457
2021 Q2	–	Sell	-859	Closed	-$98K	–	10535
2021 Q1	$98K	Buy	+859	New	+$95.2K	﹤0.01%	8655
2020 Q4	–	Sell	-157	Closed	-$6K	–	8231
2020 Q3	$6K	Sell	157 -5	-3%	-$222	﹤0.01%	7059
2020 Q2	$13K	Buy	+162	New	+$14.8K	﹤0.01%	6985
2019 Q1	–	Sell	-101	Closed	-$30K	–	5755
2018 Q4	$30K	Buy	+101	New	+$24.1K	﹤0.01%	4759
2016 Q2	–	Sell	-197	Closed	-$65K	–	4695
2016 Q1	$65K	Buy	+197	New	+$64.9K	﹤0.01%	3937
2014 Q4	–	Sell	-4	Closed	-$52K	–	3121
2014 Q3	$52K	Buy	+4	New	+$51.3K	﹤0.01%	2417
2014 Q1	–	Sell	-1	Closed	-$19K	–	3132
2013 Q4	$19K	Buy	+1	New	+$13.3K	﹤0.01%	2264

Other funds holding CSCI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Jane Street's CSCI Position: Q3 2022 in Review

Jane Street sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2022, closing a stake of 173 shares — an estimated $3K sold.

Jane Street first reported a position in CSCI in Q4 2013 and held it in 8 quarters. The position peaked at $98K in Q1 2021. 12 funds tracked by Wall St. Rank hold CSCI as of Q3 2022.

Jane Street reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Jane Street sold 173 COSCIENS Biopharma Inc. Common Stock shares in Q3 2022, an estimated $3K.
Jane Street first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2013 and held it in 8 quarters.
Jane Street's COSCIENS Biopharma Inc. Common Stock position peaked at $98K in Q1 2021.
12 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2022.

Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.